Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Mesoblast
Mesoblast
Mesoblast poised to file cell therapy for GVHD in US
Pharmaforum
Wed, 04/17/19 - 09:44 am
Mesoblast
stem cells
graft vs host disease
FDA
remestemcel-L
Mesoblast defends stem cell therapy for heart failure after trial miss
Fierce Biotech
Wed, 11/14/18 - 10:01 am
Mesoblast
stem cells
clinical trials
heart failure
Celgene buys into Mesoblast's stem cell pipeline in regenerative med pact
Fierce Biotech
Mon, 04/13/15 - 10:59 am
Celgene
Mesoblast
regenerative medicine
stem cells
Biotechnology companies hunting for the keys to immortality
FT.com
Thu, 03/27/14 - 05:09 pm
Mesoblast
aging
Calico
AlloCure
stem cells
Gilead Sciences
Mesoblast Is No Match For Pluristem's IP And Manufacturing
Seeking Alpha
Thu, 01/16/14 - 07:26 am
Mesoblast
stem cells
Pluristem
Who Will Win The Stem Cell Race?
Seeking Alpha
Tue, 12/24/13 - 09:45 am
stem cells
Cytori
Athersys
Thermogenesis
Mesoblast
NeoStem
Teva gets approval from FDA for phase 3 heart failure trial
The Fly on the Wall
Thu, 10/31/13 - 08:58 am
Teva
Mesoblast
FDA
congestive heart failure
Mesenchymal Precursor Cells
Osiris exits stem cell business, sells unit to Mesoblast in $100M deal
Fierce Biotech
Fri, 10/11/13 - 09:39 am
Mesoblast
Osiris
stem cells
M&A
Pluristem Standardizes Stem Cell Therapy, Opening Door To The Future Of Medicine
Seeking Alpha
Mon, 11/5/12 - 12:49 pm
Pluristem
stem cells
Mesoblast
Osiris
Thermo Fisher
The Next Big Growth Sector In Health Care: Stem Cell Therapy
Seeking Alpha
Tue, 09/4/12 - 11:54 am
stem cells
Advanced Cell Technology
Advanced Micro Devices
Arthersys
Neuralstem
Mesoblast
Pfizer
Teva Pharmaceuticals
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
FACTBOX-Stem cell advances focus on heart, inflammation
Reuters
Mon, 12/5/11 - 12:25 pm
stem cells
inflammation
Aastrom
Arthersys
Baxter
Celgene
Cytori
Mesoblast
Fibrocell Science
StemCells
Pluristem
Osiris
Pharmicell
NeoStem
Neuralstem
Gamida Cell
Athersys Shares Poised To Move Higher
Seeking Alpha
Fri, 12/2/11 - 09:31 am
Athersys
Pfizer
Mesoblast
Cephalon
Geron
Teva Pharma Is ‘Ideal Partner,’ Mesoblast CEO Itescu Says
Bloomberg
Tue, 05/3/11 - 07:28 am
Teva Pharmaceuticals
Mesoblast
Time to Buy Into Stem Cells?
Motley Fool
Tue, 02/1/11 - 08:23 am
stem cells
Geron
Neuralstem
StemCells
Pfizer
GSK
Cephalon
Mesoblast
Merck
Alnylam
Cephalon Stem Cell Deal Catches Analysts Off-Guard
Seeking Alpha
Mon, 12/13/10 - 10:08 am
stem cells
Cephalon
Mesoblast
Cephalon Buys Mesoblast Stake, Drug Rights in Potential $2 Billion Deal
Bloomberg
Wed, 12/8/10 - 12:45 pm
Cephalon
Mesoblast
stem cells
Stem Cell Developer Mesoblast Seeks Bone Marrow Therapy by 2012
Bloomberg
Wed, 05/12/10 - 03:01 pm
stem cells
Mesoblast
Angioblast
Pages
« first
‹ previous
1
2